Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07430501
What this trial is testing

Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Hospital Universitari Vall d'Hebron Research Institute 7,720
Not applicableUnknownNCT04774601
What this trial is testing

Elastography in Chronic Liver Disease in Children

Who this might be right for
Chronic Liver Disease
Assiut University 50
Not applicableNot Yet RecruitingNCT07303829
What this trial is testing

Laparoscopic Approach to Pyogenic Liver Abscess

Who this might be right for
Liver Abscess, Pyogenic
Assiut University 30
Not applicableLooking for participantsNCT07157631
What this trial is testing

Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial

Who this might be right for
Liver TransplantationTranexamic AcidEnd-stage Liver Disease (ESLD)
RenJi Hospital 1,546
Early research (Phase 1)Study completedNCT04418401
What this trial is testing

Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 30
Testing effectiveness (Phase 2)Study completedNCT03421431
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 134
Post-approval studies (Phase 4)Looking for participantsNCT07322237
What this trial is testing

DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis

Who this might be right for
Cirrhotic CardiomyopathyEmpagliflozinCardiometabolic Risk Factors+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh 400
Early research (Phase 1)Study completedNCT00406237
What this trial is testing

Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis

Who this might be right for
Liver Cirrhosis, Biliary
Wyeth is now a wholly owned subsidiary of Pfizer 8
Not applicableLooking for participantsNCT06621472
What this trial is testing

Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery

Who this might be right for
Cancer Liver
Cairo University 90
Early research (Phase 1)Study completedNCT01949545
What this trial is testing

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment

Who this might be right for
Solid TumorsHematologic MalignanciesHepatic Impairment
Amgen 46
Testing effectiveness (Phase 2)Study completedNCT01777295
What this trial is testing

Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

Who this might be right for
Hepatitis B
GlaxoSmithKline 81
Large-scale testing (Phase 3)Study completedNCT01979939
What this trial is testing

UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 416
Early research (Phase 1)Study completedNCT01231529
What this trial is testing

GSK1349572 Hepatic Impairment Study

Who this might be right for
Healthy SubjectsHepatic ImpairmentInfection, Human Immunodeficiency Virus+1 more
ViiV Healthcare 16
Not applicableActive Not RecruitingNCT05661331
What this trial is testing

VIATORR Device Registry

Who this might be right for
Chronic Liver Disease
W.L.Gore & Associates 196
Not applicableStudy completedNCT01674972
What this trial is testing

Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls

Who this might be right for
Non Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis
University Hospital, Basel, Switzerland 102
Not applicableStudy completedNCT00817895
What this trial is testing

Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 150
Post-approval studies (Phase 4)Study completedNCT03849729
What this trial is testing

Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery

Who this might be right for
ObesityMorbid ObesityBariatric Surgery+2 more
Hospital Juarez de Mexico 92
Post-approval studies (Phase 4)UnknownNCT01438437
What this trial is testing

Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis

Who this might be right for
Hepatocellular Carcinoma
All India Institute of Medical Sciences 54
Not applicableStudy completedNCT06161766
What this trial is testing

Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease

Who this might be right for
Liver CirrhosisHepato-Renal SyndromeChronic Kidney Diseases
University Hospital Freiburg 490
Post-approval studies (Phase 4)Study completedNCT02463331
What this trial is testing

Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial

Who this might be right for
Autoimmune Hepatitis
University of Sao Paulo General Hospital 57
Next Page